Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 2939 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Read this article

 


    Article Cited by others

CURRENT THEMES

The new patent regime: Implications for patients in India

Andrade Chittaranjan, Shah Nilesh, Chandra Sarvesh

Year : 2007| Volume: 49| Issue : 1 | Page no: 56-59

   This article has been cited by
 
1 Moving psychopharmacological drug development to the developing world
TS Sathyanarayana Rao, Chittaranjan Andrade
Indian Journal of Psychiatry. 2014; 56(2): 105
[Pubmed]  [Google Scholar] [DOI]
2 Unfettered Consumer Access to Affordable Therapies in the Post-TRIPS Era: A Dead-End Journey for Patients? Kenya and India Case Studies
Brenda Pamela Mey
The Journal of World Intellectual Property. 2010;
[HTML Full text]  [Google Scholar] [DOI]
3 Desvenlafaxine
Chittaranjan Andrade
Indian Journal of Psychiatry. 2009; 51(4): 320
[Pubmed]  [Google Scholar] [DOI]
4 Molecular mechanisms underlying electroconvulsive therapy-induced amnestic deficits: A decade of research
Chittaranjan Andrade
Indian Journal of Psychiatry. 2008; 50(4): 244
[Pubmed]  [Google Scholar] [DOI]